B-cell prolymphocytic leukemia other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 5: Line 5:


==Overview==
==Overview==
Other diagnostic studies for acute lymphoblastic leukemia include [[Immunophenotyping]].
Another diagnostic study for B-cell prolymphocytic leukemia includes [[immunophenotyping]].


==Immunophenotyping==
==Immunophenotyping==
The flow cytometric [[immunophenotyping]] indicates that the most common malignant cells are positive for:<ref name=PLL>{{cite web | title = National Cancer Institute| url =http://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/}}</ref>
[[Flow cytometry|Flow cytometric]] [[immunophenotyping]] indicates that the most common [[Malignant|malignant cells]] are positive for:<ref name="PLL">{{cite web | title = National Cancer Institute| url =http://seer.cancer.gov/seertools/hemelymph/51f6cf58e3e27c3994bd53f9/}}</ref>
 
* CD20
* CD22
* CD23
* CD79a
* CD79b
* FMC7
* Strong surface IgM +/- IgD


* [[CD20]]
* [[CD22]]
* [[CD23]]
* [[CD79a]]
* [[CD79b]]
* [[FMC7]]
* Strong [[Immunoglobulin M|surface IgM]] +/- [[IgD]]


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Leukemia]]
[[Category: Lymphocytic leukemia]]
[[Category:Disease]]
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Oncology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 19:33, 8 April 2019

B-cell prolymphocytic leukemia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell prolymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

B-cell prolymphocytic leukemia other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of B-cell prolymphocytic leukemia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on B-cell prolymphocytic leukemia other diagnostic studies

CDC on B-cell prolymphocytic leukemia other diagnostic studies

B-cell prolymphocytic leukemia other diagnostic studies in the news

Blogs on B-cell prolymphocytic leukemia other diagnostic studies

Directions to Hospitals Treating B-cell prolymphocytic leukemia

Risk calculators and risk factors for B-cell prolymphocytic leukemia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]

Overview

Another diagnostic study for B-cell prolymphocytic leukemia includes immunophenotyping.

Immunophenotyping

Flow cytometric immunophenotyping indicates that the most common malignant cells are positive for:[1]

References

  1. "National Cancer Institute".


Template:WikiDoc Sources